Single nucleotide polymorphisms in the promoter region of the IL1B gene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomib
暂无分享,去创建一个
U. Vogel | A. Vangsted | T. Klausen | N. Abildgaard | B. Nexø | N. F. Andersen | P. Gimsing | H. Gregersen